Qiagen, Abbott Enter into Molecular Dx Pact

Under the terms of the deal, Qiagen will receive kits from Abbott for a PCR-based molecular assay for HIV-1 viral load testing in the US and Canada. In return, it will provide Abbott certain key products needed for a PCR-based HPV test in the US and Canada.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.